-
Living With Chronic Blood Cancer
Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Survivor Profile
Changing CourseInitially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
-
Healthy Habits
Make Time for TeaA daily tea habit is associated with improved survival for those with colorectal cancer.
by Anne Danahy
-
Q&A
Pulling Back the Research CurtainJessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.
by Marci A. Landsmann
-
Lung Cancer Patients Face Worse Survival After Wildfire Exposure
Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
by Sandra Gordon
-
Choosing Between Lung Cancer Surgery and Radiation
Study suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
by Jon Kelvey
-
Understanding Disparities in Melanoma Diagnosis
Black men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
-
After Colorectal Cancer, Survivors Face Higher Risk for a Second Cancer
Researchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
by Sandra Gordon
-
Sunscreen Is Just the Start
Experts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.
by Kyle Bagenstose
-
Ovarian Cancer: A Quest to Extend Remissions
New treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona